Literature DB >> 20166371

Hypophosphataemic osteomalacia in neurofibromatosis.

Manish Chadha1, Ajay Pal Singh, Arun Pal Singh.   

Abstract

Oncogenic Osteomalacia syndrome is associated with mesenchymal tumours, caused by a protein secreted from tumours which inhibits tubular renal phosphate absorption and reduces 1,25 dihydroxy vitamin-D renal conversion. It manifests as osteomalacia with hypophosphataemia and hyperphosphaturia. Association of neurofibromatosis with oncogenic osteomalacia is unusual. We report a rare case of oncogenic osteomalacia with generalized neurofibromatosis which presented to us as pathological fracture.

Entities:  

Mesh:

Year:  2009        PMID: 20166371

Source DB:  PubMed          Journal:  Acta Orthop Belg        ISSN: 0001-6462            Impact factor:   0.500


  7 in total

Review 1.  FGF23 and Phosphate Wasting Disorders.

Authors:  Xianglan Huang; Yan Jiang; Weibo Xia
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

2.  Striking pathology gold: a singular experience with daily reverberations: sinonasal hemangiopericytoma (glomangiopericytoma) and oncogenic osteomalacia.

Authors:  Margaret Brandwein-Gensler; Gene P Siegal
Journal:  Head Neck Pathol       Date:  2012-03-20

3.  Oncogenic osteomalacia: Problems in diagnosis and long-term management.

Authors:  Ish K Dhammi; Anil K Jain; Ajay Pal Singh; Puneet Mishra; Saurabh Jain
Journal:  Indian J Orthop       Date:  2010-10       Impact factor: 1.251

4.  Hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis: Case report and literature review.

Authors:  Aman Gupta; Abhishek Dwivedi; Priyanka Patel; Somya Gupta
Journal:  Indian J Radiol Imaging       Date:  2015 Jan-Mar

5.  Neurofibromatosis type 1 associated with hypophosphatemic osteomalacia due to hypersecretion of fibroblast growth factor 23: a case report.

Authors:  Takahiko Obo; Nobuyuki Koriyama; Akinori Tokito; Kazuma Ogiso; Yoshihiko Nishio
Journal:  J Med Case Rep       Date:  2020-05-09

6.  Hypophosphatemic osteomalacia in neurofibromatosis 1 associated with intracranial gliomas and congenital renal agenesis: A rare case report and review of the literature.

Authors:  Angelos Kaspiris; Elias Vasiliadis; Dimitra Melissaridou; Ilias D Iliopoulos; Panayiotis J Papagelopoulos; Olga D Savvidou
Journal:  J Orthop Case Rep       Date:  2022-02

Review 7.  Current Aspects on the Pathophysiology of Bone Metabolic Defects during Progression of Scoliosis in Neurofibromatosis Type 1.

Authors:  Angelos Kaspiris; Olga D Savvidou; Elias S Vasiliadis; Argyris C Hadjimichael; Dimitra Melissaridou; Stella Iliopoulou-Kosmadaki; Ilias D Iliopoulos; Evangelia Papadimitriou; Efstathios Chronopoulos
Journal:  J Clin Med       Date:  2022-01-15       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.